Sequenom Signs Supply Deal for T21 Test with Illumina; Firms to Collaborate on Regulatory Approval
July 12, 2011
Sequenom Signs Supply Deal for T21 Test with Illumina; Firms to Collaborate on Regulatory Approval
Under the three-year supply agreement for Illumina's HiSeq 2000 platform, Sequenom and its subsidiaries will purchase sequencing equipment and consumables for use in the development of its Down syndrome test.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Considering Illumina, SOLiD for Down Syndrome Test; Plans to Launch LDT by End of 2011
May 18, 2010 / In Sequence - Sequenom Ramps up Hiring, Licenses Additional Technology as it Nears Launch of T21 Test
August 9, 2011 / Clinical Sequencing News - Illumina Sees Clinical Applications for MiSeq; Plans FDA Submission in 2012
August 3, 2011 / Clinical Sequencing News - Sequenom, Illumina Ink Supply Agreement
July 11, 2011 / GenomeWeb Daily News - Illumina Mulls FDA Clearance of HiSeq 2000; Sees Strong Demand for Whole-Genome Sequencing
September 21, 2010 / In Sequence